CMS/NCI Will Test Model For Evidence-Based Reimbursement
Executive Summary
A collaboration between the National Cancer Institute and the Centers for Medicare & Medicaid Services will examine cancer therapies as a model for evidence-based reimbursement, NCI Director Andrew von Eschenbach, MD, told the Milken Institute Global Conference in Los Angeles April 26-27
You may also be interested in...
Howdy Partners: Von Eschenbach Pledges More Collaborations With NIH
FDA Acting Commissioner Andrew von Eschenbach will champion better coordination with other federal agencies and the private sector during his temporary tenure at the agency's helm
Howdy Partners: Von Eschenbach Pledges More Collaborations With NIH
FDA Acting Commissioner Andrew von Eschenbach will champion better coordination with other federal agencies and the private sector during his temporary tenure at the agency's helm
NCI Will Help CMS Make “Tough Decisions” On Cancer Drug Coverage
The Centers for Medicare & Medicaid Services will be working in collaboration with the National Cancer Institute to help make some "tough" decisions about cancer coverage, CMS Administrator Mark McClellan said June 15 at a Manhattan Institute luncheon in New York